Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors. 2012

Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
Department of Psychology, University of Wisconsin, Madison, Wisconsin 53706, USA. berridge@wisc.edu

BACKGROUND Psychostimulants improve a variety of cognitive and behavioral processes in patients with attention-deficit/hyperactivity disorder (ADHD). Limited observations suggest a potentially different dose-sensitivity of prefrontal cortex (PFC)-dependent function (narrow inverted-U-shaped dose-response curves) versus classroom/overt behavior (broad inverted U) in children with ADHD. Recent work in rodents demonstrates that methylphenidate (MPH; Ritalin) elicits a narrow inverted-U-shaped improvement in performance in PFC-dependent tests of working memory. The current studies first tested the hypothesis that PFC-dependent tasks, in general, display narrow dose sensitivity to the beneficial actions of MPH. METHODS The effects of varying doses of MPH were examined on performance of rats in two tests of PFC-dependent cognition, sustained attention and attentional set shifting. Additionally, the effect of pretreatment with the α₁-antagonist prazosin (.5 mg/kg) on MPH-induced improvement in sustained attention was examined. RESULTS MPH produced a broad inverted-U-shaped facilitation of sustained attention and attentional set shifting. Prior research indicates α₁-receptors impair, whereas α₂-receptors improve, working memory. In contrast, attentional set shifting is improved with α₁-receptor activation, whereas α₂-receptors exert minimal effects in this task. Given the similar dose sensitivity of sustained attention and attentional set-shifting tasks, additional studies examined whether α₁-receptors promote sustained attention, similar to attentional set shifting. In these studies, MPH-induced improvement in sustained attention was abolished by α₁-receptor blockade. CONCLUSIONS PFC-dependent processes display differential sensitivity to the cognition-enhancing actions of psychostimulants that are linked to the differential involvement of α₁- versus α₂-receptors in these processes. These observations have significant preclinical and clinical implications.

UI MeSH Term Description Entries
D008297 Male Males
D008774 Methylphenidate A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE. Centedrin,Concerta,Daytrana,Equasym,Metadate,Methylin,Methylphenidate Hydrochloride,Phenidylate,Ritalin,Ritalin-SR,Ritaline,Tsentedrin,Hydrochloride, Methylphenidate,Ritalin SR
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D003216 Conditioning, Operant Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. Instrumental Learning,Learning, Instrumental,Operant Conditioning,Conditionings, Operant,Instrumental Learnings,Learnings, Instrumental,Operant Conditionings
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001288 Attention Focusing on certain aspects of current experience to the exclusion of others. It is the act of heeding or taking notice or concentrating. Focus of Attention,Selective Attention,Social Attention,Attention Focus,Attention, Selective,Attention, Social,Selective Attentions
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
January 2021, Cell,
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
August 2012, Biological psychiatry,
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
June 2016, Human brain mapping,
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
May 2013, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
August 2017, Learning & memory (Cold Spring Harbor, N.Y.),
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
July 1980, British journal of pharmacology,
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
January 2022, Nature communications,
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
April 2024, Quarterly journal of experimental psychology (2006),
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
June 2011, Biological psychiatry,
Craig W Berridge, and Jed S Shumsky, and Matt E Andrzejewski, and Jill A McGaughy, and Robert C Spencer, and David M Devilbiss, and Barry D Waterhouse
June 2007, Psychology and aging,
Copied contents to your clipboard!